Document is current
Any future updates will be listed below
-
Authors
Lee, Hyo Sang https://orcid.org/0000-0001-7740-8619
Kwon, Hyun Woo
Lim, Seok-Byung
Kim, Jin Cheon
Yu, Chang Sik
Hong, Yong Sang
Kim, Tae Won
Oh, Minyoung
Han, Sangwon
Oh, Jae Hwan
Park, Sohyun
Kim, Tae-Sung
Kim, Seok-ki
Kim, Hyun Joo
Kwak, Jae Young
Oh, Ho-Suk
Kim, Sungeun
Kwak, Jung-Myun
Lee, Ji Sung
Kim, Jae Seung
-
Funding
Funding for this research was provided by:
Korea Health and Welfare Information Service
Gangneung Asan Hospital (2021IB001)
national research foundation of korea (2021R1G1A1009606)
Korea University (K2023081)
- License Information
-
More Information
Article History
Received: 7 April 2022
Revised: 11 August 2022
Accepted: 5 September 2022
First Online: 17 September 2022
Declarations
:
: The scientific guarantors of this publication are Hyo Sang Lee and Ji Sung Lee.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: Ji Sung Lee (a PhD statistician) kindly provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects (120 patients in the development cohort) have been previously reported in <i>J Nucl Med</i>. 2014; 55(4):582-9. The previous study was a prognostic marker study that analyzed the prognostic value of FDG metabolic parameters. The current study is about the prognostic modelling using the FDG metabolic parameter, which is the natural extension of the previous study.
: • retrospective• prognostic study• multicenter study
